{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:40:01Z","timestamp":1749318001966,"version":"3.41.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Contrast-induced nephropathy is the leading cause of acute kidney injury in hospital settings. Practitioners must have a comprehensive understanding of preventive interventions. This article provides a mnemonic NPs can use to prevent contrast-induced nephropathy. The mnemonic, CHIPS, addresses <jats:underline>C<\/jats:underline>ontrast minimizations, <jats:underline>H<\/jats:underline>emofiltration, <jats:underline>I<\/jats:underline>so-osmolar\/low osmolar contrast, <jats:underline>P<\/jats:underline>harmacologic interventions, and <jats:underline>S<\/jats:underline>aline I.V. hydration.<\/jats:p>","DOI":"10.1097\/01.npr.0000804164.94431.fc","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T23:00:38Z","timestamp":1637622038000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CHIPS"],"prefix":"10.1097","volume":"46","author":[{"given":"Mohamed Toufic","family":"El Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calla","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijcard.2016.11.019","article-title":"Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study","volume":"227","author":"Sato","year":"2017","journal-title":"Int J Cardiol"},{"issue":"7","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0003319718803677","article-title":"Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"70","author":"Sun","year":"2019","journal-title":"Angiology"},{"issue":"8","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/heartjnl-2014-306962","article-title":"Contrast-induced nephropathy following angiography and cardiac interventions","volume":"102","author":"Rear","year":"2016","journal-title":"Heart"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12882-021-02469-w","article-title":"Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19","volume":"22","author":"Kistner","year":"2021","journal-title":"BMC Nephrol"},{"issue":"2","key":"R5-20250607","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00392-017-1166-2","article-title":"Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures","volume":"107","author":"Feldkamp","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.nurpra.2018.08.032","article-title":"Mnemonic to assist in management of liver cirrhosis","volume":"14","author":"El Hussein","year":"2018","journal-title":"J Nurse Pract"},{"issue":"1","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ejcts\/ezy289","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"55","author":"Sousa-Uva","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"e004122","DOI":"10.1161\/CIRCINTERVENTIONS.116.004122","article-title":"Prevention of contrast-induced renal failure for the interventional cardiologist","volume":"9","author":"Chau","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","article-title":"Contrast-induced nephropathy: from pathophysiology to preventive strategies","volume":"32","author":"Azzalini","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.ajkd.2019.05.022","article-title":"The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk","volume":"75","author":"Rudnick","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2017.06.009","article-title":"Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies","volume":"180","author":"Mamoulakis","year":"2017","journal-title":"Pharmacol Ther"},{"issue":"2","key":"R12-20250607","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004498","article-title":"Preprocedural prediction model for contrast-induced nephropathy patients","volume":"6","author":"Yin","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"R13-20250607","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1007\/s00330-015-4155-8","article-title":"Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention","volume":"26","author":"Tao","year":"2016","journal-title":"Eur Radiol"},{"issue":"1","key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/bmdcn\/2018080101","article-title":"The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)","volume":"8","author":"Yang","year":"2018","journal-title":"Biomedicine (Taipei)"},{"issue":"13","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"21","DOI":"10.15171\/jrip.2016.05","article-title":"Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography","volume":"5","author":"Assareh","year":"2016","journal-title":"J Renal Inj Prev"},{"issue":"4","key":"R18-20250607","first-page":"268","article-title":"Cystatin C is indispensable for evaluation of kidney disease","volume":"28","author":"Grubb","year":"2017","journal-title":"EJIFCC"},{"issue":"3","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ejcts\/ezv199","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis","volume":"49","author":"Zhou","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/IJNRD.S105124","article-title":"The potential use of biomarkers in predicting contrast-induced acute kidney injury","volume":"9","author":"Andreucci","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"22","key":"R21-20250607","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"R22-20250607","first-page":"259","article-title":"Contrast minimization with the new-generation DyeVert Plus system for contrast reduction and real-time monitoring during coronary and peripheral procedures: first experience","volume":"29","author":"Corcione","year":"2017","journal-title":"J Invasive Cardiol"},{"issue":"9","key":"R23-20250607","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1177\/2047487315614493","article-title":"Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention","volume":"23","author":"Barbieri","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ccd.28640","article-title":"Effectiveness of high flow-volume intermittent hemodiafiltration during and after intervention to prevent contrast-induced nephropathy in patients with advanced chronic kidney disease: a pilot study","volume":"96","author":"Oyamada","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"14","key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa023204","article-title":"The prevention of radiocontrast-agent-induced nephropathy by hemofiltration","volume":"349","author":"Marenzi","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"R26-20250607","first-page":"e3284","article-title":"The prevention and management of contrast-induced acute kidney injury: a mini-review of the literature","volume":"10","author":"Ali","year":"2018","journal-title":"Cureus"},{"issue":"4","key":"R27-20250607","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ccd.26106","article-title":"One-year results of the ICON (ionic versus non-ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study","volume":"87","author":"Giustino","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"R28-20250607","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4070\/kcj.2020.0307","article-title":"Contrast induced nephropathy and 2-year outcomes of iso-osmolar compared with low-osmolar contrast media after elective percutaneous coronary intervention","volume":"51","author":"Du","year":"2021","journal-title":"Korean Circ J"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.biopha.2018.07.068","article-title":"Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy","volume":"106","author":"Yang","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"R30-20250607","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000326269","article-title":"Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2011","journal-title":"Am J Nephrol"},{"issue":"27","key":"R31-20250607","doi-asserted-by":"crossref","first-page":"e7384","DOI":"10.1097\/MD.0000000000007384","article-title":"Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: a meta-analysis of 15 randomized controlled trials","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"R32-20250607","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.0548","article-title":"High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial","volume":"315","author":"Billings","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"R33-20250607","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med"},{"key":"R34-20250607","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5727309","article-title":"Contrast-induced nephropathy: update on the use of crystalloids and pharmacological measures","volume":"2018","author":"Patschan","year":"2018","journal-title":"Int J Nephrol"},{"issue":"9931","key":"R35-20250607","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ahj.2015.12.005","article-title":"RenalGuard system in high-risk patients for contrast-induced acute kidney injury","volume":"173","author":"Briguori","year":"2016","journal-title":"Am Heart J"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000804164.94431.fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:01:00Z","timestamp":1749315660000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000804164.94431.fc"}},"subtitle":["Prevention of contrast-induced nephropathy before and after cardiac catheterization"],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000804164.94431.fc","relation":{},"ISSN":["0361-1817"],"issn-type":[{"type":"print","value":"0361-1817"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}